Medline Inc. (NASDAQ: MDLN) Stock Competitors & Peer Comparison
See MDLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDLN | $40.77 | -0.35% | 37B | 30.89 | $1.36 | N/A |
| ISRG | $442.86 | -1.60% | 155.8B | 46.73 | $9.62 | N/A |
| BDX | $215.15 | +1.19% | 58.4B | 16.50 | $13.00 | +1.86% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +1.86% |
| RMD | $241.20 | +3.32% | 33.6B | 20.69 | $11.53 | +1.06% |
| WST | $412.70 | +0.04% | 28.8B | 44.88 | $9.20 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $89.29 | -0.88% | 15.1B | 12.48 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +1.86% |
| BAX | $25.94 | -1.84% | 13.6B | 12.66 | $2.08 | +0.15% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
MDLN vs ISRG Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ISRG has a market cap of 155.8B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ISRG trades at $442.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ISRG's P/E ratio is 46.73. In terms of profitability, MDLN's ROE is +0.05%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, MDLN is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDX)
MDLN vs BDX Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BDX has a market cap of 58.4B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BDX trades at $215.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BDX's P/E ratio is 16.50. In terms of profitability, MDLN's ROE is +0.05%, compared to BDX's ROE of +0.04%. Regarding short-term risk, MDLN is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
MDLN vs BDXA Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BDXA's P/E ratio is 45.70. In terms of profitability, MDLN's ROE is +0.05%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, MDLN is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check BDXA's competition here
ResMed Inc. (NYSE: RMD)
MDLN vs RMD Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, RMD has a market cap of 33.6B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while RMD trades at $241.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas RMD's P/E ratio is 20.69. In terms of profitability, MDLN's ROE is +0.05%, compared to RMD's ROE of +0.25%. Regarding short-term risk, MDLN is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check RMD's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
MDLN vs WST Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, WST has a market cap of 28.8B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while WST trades at $412.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas WST's P/E ratio is 44.88. In terms of profitability, MDLN's ROE is +0.05%, compared to WST's ROE of +0.21%. Regarding short-term risk, MDLN is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
MDLN vs HOLX Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas HOLX's P/E ratio is 31.54. In terms of profitability, MDLN's ROE is +0.05%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, MDLN is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
MDLN vs SOLV Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, SOLV has a market cap of 15.1B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while SOLV trades at $89.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas SOLV's P/E ratio is 12.48. In terms of profitability, MDLN's ROE is +0.05%, compared to SOLV's ROE of +0.03%. Regarding short-term risk, MDLN is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
MDLN vs BDXB Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BDXB's P/E ratio is 7.60. In terms of profitability, MDLN's ROE is +0.05%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, MDLN is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
MDLN vs BAX Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BAX has a market cap of 13.6B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BAX trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BAX's P/E ratio is 12.66. In terms of profitability, MDLN's ROE is +0.05%, compared to BAX's ROE of -0.12%. Regarding short-term risk, MDLN is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
MDLN vs COO Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, COO has a market cap of 12B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while COO trades at $62.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas COO's P/E ratio is 13.80. In terms of profitability, MDLN's ROE is +0.05%, compared to COO's ROE of +0.07%. Regarding short-term risk, MDLN is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
MDLN vs RGEN Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, RGEN has a market cap of 11B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while RGEN trades at $166.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas RGEN's P/E ratio is 95.86. In terms of profitability, MDLN's ROE is +0.05%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, MDLN is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
MDLN vs AVTR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, AVTR has a market cap of 10.7B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while AVTR trades at $15.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas AVTR's P/E ratio is 18.50. In terms of profitability, MDLN's ROE is +0.05%, compared to AVTR's ROE of +0.06%. Regarding short-term risk, MDLN is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
MDLN vs ATR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ATR has a market cap of 9.1B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ATR trades at $141.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ATR's P/E ratio is 25.01. In terms of profitability, MDLN's ROE is +0.05%, compared to ATR's ROE of +0.10%. Regarding short-term risk, MDLN is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
MDLN vs BLCO Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BLCO has a market cap of 7.6B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BLCO trades at $21.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BLCO's P/E ratio is 32.78. In terms of profitability, MDLN's ROE is +0.05%, compared to BLCO's ROE of -0.02%. Regarding short-term risk, MDLN is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
MDLN vs TFX Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, TFX has a market cap of 6.2B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while TFX trades at $153.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas TFX's P/E ratio is 17.87. In terms of profitability, MDLN's ROE is +0.05%, compared to TFX's ROE of +0.10%. Regarding short-term risk, MDLN is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
MDLN vs MMSI Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, MMSI has a market cap of 5.3B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while MMSI trades at $86.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas MMSI's P/E ratio is 22.52. In terms of profitability, MDLN's ROE is +0.05%, compared to MMSI's ROE of +0.10%. Regarding short-term risk, MDLN is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
MDLN vs ICUI Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ICUI has a market cap of 4.5B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ICUI trades at $178.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ICUI's P/E ratio is 22.25. In terms of profitability, MDLN's ROE is +0.05%, compared to ICUI's ROE of +0.03%. Regarding short-term risk, MDLN is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
MDLN vs PLSE Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, PLSE has a market cap of 4.2B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while PLSE trades at $54.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas PLSE's P/E ratio is -48.29. In terms of profitability, MDLN's ROE is +0.05%, compared to PLSE's ROE of -0.78%. Regarding short-term risk, MDLN is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check PLSE's competition here
Envista Holdings Corp (NYSE: NVST)
MDLN vs NVST Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, NVST has a market cap of 4.1B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while NVST trades at $24.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas NVST's P/E ratio is 17.21. In terms of profitability, MDLN's ROE is +0.05%, compared to NVST's ROE of +0.21%. Regarding short-term risk, MDLN is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check NVST's competition here
Stevanato Group S.p.A. (NYSE: STVN)
MDLN vs STVN Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, STVN has a market cap of 3.8B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while STVN trades at $14.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas STVN's P/E ratio is 20.95. In terms of profitability, MDLN's ROE is +0.05%, compared to STVN's ROE of +0.09%. Regarding short-term risk, MDLN is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STVN's competition here
AtriCure, Inc. (NASDAQ: ATRC)
MDLN vs ATRC Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ATRC trades at $56.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ATRC's P/E ratio is 1786.65. In terms of profitability, MDLN's ROE is +0.05%, compared to ATRC's ROE of +0.03%. Regarding short-term risk, MDLN is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRC's competition here
Azenta, Inc. (NASDAQ: AZTA)
MDLN vs AZTA Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, AZTA has a market cap of 2.1B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while AZTA trades at $45.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas AZTA's P/E ratio is 116.43. In terms of profitability, MDLN's ROE is +0.05%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, MDLN is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AZTA's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
MDLN vs XRAY Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while XRAY trades at $9.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas XRAY's P/E ratio is 6.83. In terms of profitability, MDLN's ROE is +0.05%, compared to XRAY's ROE of -0.09%. Regarding short-term risk, MDLN is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check XRAY's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
MDLN vs BLFS Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BLFS's P/E ratio is 37.49. In terms of profitability, MDLN's ROE is +0.05%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, MDLN is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
MDLN vs KMTS Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, KMTS has a market cap of 1.9B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while KMTS trades at $29.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas KMTS's P/E ratio is -11.94. In terms of profitability, MDLN's ROE is +0.05%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, MDLN is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check KMTS's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
MDLN vs LMAT Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while LMAT trades at $78.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas LMAT's P/E ratio is 29.15. In terms of profitability, MDLN's ROE is +0.05%, compared to LMAT's ROE of +0.15%. Regarding short-term risk, MDLN is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check LMAT's competition here
STAAR Surgical Company (NASDAQ: STAA)
MDLN vs STAA Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while STAA trades at $26.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas STAA's P/E ratio is 46.82. In terms of profitability, MDLN's ROE is +0.05%, compared to STAA's ROE of +0.00%. Regarding short-term risk, MDLN is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
MDLN vs ATRI Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ATRI's P/E ratio is 64.50. In terms of profitability, MDLN's ROE is +0.05%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, MDLN is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
MDLN vs ANGO Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ANGO has a market cap of 522.3M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ANGO trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ANGO's P/E ratio is -31.85. In terms of profitability, MDLN's ROE is +0.05%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, MDLN is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
MDLN vs MMEDV Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas MMEDV's P/E ratio is N/A. In terms of profitability, MDLN's ROE is +0.05%, compared to MMEDV's ROE of N/A. Regarding short-term risk, MDLN is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
MDLN vs EMBC Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, EMBC has a market cap of 370M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while EMBC trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas EMBC's P/E ratio is 2.51. In terms of profitability, MDLN's ROE is +0.05%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, MDLN is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
MDLN vs SMTI Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, SMTI has a market cap of 290.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while SMTI trades at $32.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas SMTI's P/E ratio is -526.83. In terms of profitability, MDLN's ROE is +0.05%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, MDLN is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
MDLN vs OSUR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, OSUR has a market cap of 245.5M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while OSUR trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas OSUR's P/E ratio is -5.16. In terms of profitability, MDLN's ROE is +0.05%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, MDLN is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check OSUR's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
MDLN vs PDEX Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, PDEX has a market cap of 228.8M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while PDEX trades at $69.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas PDEX's P/E ratio is 19.59. In terms of profitability, MDLN's ROE is +0.05%, compared to PDEX's ROE of +0.26%. Regarding short-term risk, MDLN is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check PDEX's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
MDLN vs UTMD Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, UTMD has a market cap of 208.1M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while UTMD trades at $73.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas UTMD's P/E ratio is 21.61. In terms of profitability, MDLN's ROE is +0.05%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, MDLN is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check UTMD's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
MDLN vs KRMD Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, KRMD has a market cap of 178.7M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while KRMD trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas KRMD's P/E ratio is -97.25. In terms of profitability, MDLN's ROE is +0.05%, compared to KRMD's ROE of -0.00%. Regarding short-term risk, MDLN is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check KRMD's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
MDLN vs NNNN Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, NNNN has a market cap of 174.8M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while NNNN trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas NNNN's P/E ratio is 26.55. In terms of profitability, MDLN's ROE is +0.05%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, MDLN is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check NNNN's competition here
Stereotaxis, Inc. (AMEX: STXS)
MDLN vs STXS Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, STXS has a market cap of 90.2M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while STXS trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas STXS's P/E ratio is -5.29. In terms of profitability, MDLN's ROE is +0.05%, compared to STXS's ROE of -1.16%. Regarding short-term risk, MDLN is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
MDLN vs AKYA Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas AKYA's P/E ratio is -1.34. In terms of profitability, MDLN's ROE is +0.05%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, MDLN is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check AKYA's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
MDLN vs POCI Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, POCI has a market cap of 55.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while POCI trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas POCI's P/E ratio is -10.98. In terms of profitability, MDLN's ROE is +0.05%, compared to POCI's ROE of -0.24%. Regarding short-term risk, MDLN is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check POCI's competition here
SkyAI, Inc. (NASDAQ: STSS)
MDLN vs STSS Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas STSS's P/E ratio is -0.02. In terms of profitability, MDLN's ROE is +0.05%, compared to STSS's ROE of -0.99%. Regarding short-term risk, MDLN is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
MDLN vs OMIC Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas OMIC's P/E ratio is -0.58. In terms of profitability, MDLN's ROE is +0.05%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, MDLN is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
MDLN vs IGAP Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas IGAP's P/E ratio is -10.52. In terms of profitability, MDLN's ROE is +0.05%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, MDLN is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IGAP's competition here
Daxor Corporation (NASDAQ: DXR)
MDLN vs DXR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, DXR has a market cap of 49.3M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while DXR trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas DXR's P/E ratio is 6.86. In terms of profitability, MDLN's ROE is +0.05%, compared to DXR's ROE of +0.13%. Regarding short-term risk, MDLN is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check DXR's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
MDLN vs HBIO Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, HBIO has a market cap of 44.1M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while HBIO trades at $9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas HBIO's P/E ratio is -26.89. In terms of profitability, MDLN's ROE is +0.05%, compared to HBIO's ROE of -1.30%. Regarding short-term risk, MDLN is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check HBIO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
MDLN vs ZJYL Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ZJYL has a market cap of 38.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ZJYL trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ZJYL's P/E ratio is 33.58. In terms of profitability, MDLN's ROE is +0.05%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, MDLN is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check ZJYL's competition here
Nephros, Inc. (NASDAQ: NEPH)
MDLN vs NEPH Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, NEPH has a market cap of 33.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while NEPH trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas NEPH's P/E ratio is 51.17. In terms of profitability, MDLN's ROE is +0.05%, compared to NEPH's ROE of +0.17%. Regarding short-term risk, MDLN is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
MDLN vs SDC Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas SDC's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.05%, compared to SDC's ROE of -1.96%. Regarding short-term risk, MDLN is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
MDLN vs MLSS Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, MLSS has a market cap of 27.9M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while MLSS trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas MLSS's P/E ratio is -6.15. In terms of profitability, MDLN's ROE is +0.05%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, MDLN is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
MDLN vs IVC Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas IVC's P/E ratio is -0.79. In terms of profitability, MDLN's ROE is +0.05%, compared to IVC's ROE of -0.46%. Regarding short-term risk, MDLN is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
MDLN vs RVP Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, RVP has a market cap of 16.6M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while RVP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas RVP's P/E ratio is -4.62. In terms of profitability, MDLN's ROE is +0.05%, compared to RVP's ROE of -0.05%. Regarding short-term risk, MDLN is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
MDLN vs BNGO Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, BNGO has a market cap of 13M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while BNGO trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas BNGO's P/E ratio is -0.36. In terms of profitability, MDLN's ROE is +0.05%, compared to BNGO's ROE of -0.85%. Regarding short-term risk, MDLN is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
MDLN vs FEMY Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, FEMY has a market cap of 12.6M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while FEMY trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas FEMY's P/E ratio is -0.33. In terms of profitability, MDLN's ROE is +0.05%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, MDLN is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
MDLN vs RGNT Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, RGNT has a market cap of 8.9M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while RGNT trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas RGNT's P/E ratio is -0.52. In terms of profitability, MDLN's ROE is +0.05%, compared to RGNT's ROE of N/A. Regarding short-term risk, MDLN is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
MDLN vs LUCY Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, LUCY has a market cap of 7.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while LUCY trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas LUCY's P/E ratio is -0.65. In terms of profitability, MDLN's ROE is +0.05%, compared to LUCY's ROE of -1.03%. Regarding short-term risk, MDLN is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
MDLN vs NSTG Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas NSTG's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.05%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, MDLN is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
MDLN vs CUPR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, CUPR has a market cap of 4.6M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while CUPR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas CUPR's P/E ratio is -1.24. In terms of profitability, MDLN's ROE is +0.05%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, MDLN is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
MDLN vs POAI Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas POAI's P/E ratio is -0.38. In terms of profitability, MDLN's ROE is +0.05%, compared to POAI's ROE of -21.19%. Regarding short-term risk, MDLN is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
MDLN vs MHUA Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas MHUA's P/E ratio is 0.25. In terms of profitability, MDLN's ROE is +0.05%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, MDLN is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
MDLN vs NXGL Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, NXGL has a market cap of 2M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while NXGL trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas NXGL's P/E ratio is -5.84. In terms of profitability, MDLN's ROE is +0.05%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, MDLN is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
MDLN vs GMVD Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas GMVD's P/E ratio is -0.01. In terms of profitability, MDLN's ROE is +0.05%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, MDLN is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
MDLN vs GMVDW Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas GMVDW's P/E ratio is N/A. In terms of profitability, MDLN's ROE is +0.05%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, MDLN is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
MDLN vs AVGR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas AVGR's P/E ratio is -0.05. In terms of profitability, MDLN's ROE is +0.05%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, MDLN is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
MDLN vs NXGLW Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, NXGLW has a market cap of 542.8K. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas NXGLW's P/E ratio is -0.01. In terms of profitability, MDLN's ROE is +0.05%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, MDLN is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
MDLN vs LUCYW Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas LUCYW's P/E ratio is N/A. In terms of profitability, MDLN's ROE is +0.05%, compared to LUCYW's ROE of -1.03%. Regarding short-term risk, MDLN is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LUCYW's competition here
Apria, Inc. (NASDAQ: APR)
MDLN vs APR Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, APR has a market cap of 0. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas APR's P/E ratio is 22.59. In terms of profitability, MDLN's ROE is +0.05%, compared to APR's ROE of +9.81%. Regarding short-term risk, MDLN is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check APR's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
MDLN vs ATRS Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ATRS's P/E ratio is 14.95. In terms of profitability, MDLN's ROE is +0.05%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, MDLN is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRS's competition here
IntriCon Corporation (NASDAQ: IIN)
MDLN vs IIN Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, IIN has a market cap of 0. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas IIN's P/E ratio is 226.45. In terms of profitability, MDLN's ROE is +0.05%, compared to IIN's ROE of -0.00%. Regarding short-term risk, MDLN is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
MDLN vs ALOG Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas ALOG's P/E ratio is 40.93. In terms of profitability, MDLN's ROE is +0.05%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, MDLN is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ALOG's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
MDLN vs HRC Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, HRC has a market cap of 0. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas HRC's P/E ratio is 41.92. In terms of profitability, MDLN's ROE is +0.05%, compared to HRC's ROE of +0.14%. Regarding short-term risk, MDLN is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HRC's competition here
Invuity, Inc. (NASDAQ: IVTY)
MDLN vs IVTY Comparison November 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 37B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, MDLN is priced at $40.77 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 30.89, whereas IVTY's P/E ratio is -3.80. In terms of profitability, MDLN's ROE is +0.05%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, MDLN is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IVTY's competition here